QMS Medical Allied Services Ltd. AGM: All 6 Resolutions Passed, Including Dividend Declaration
QMS Medical Allied Services Limited's 9th AGM on September 30, 2026, saw all six resolutions pass. Key approvals include the FY26 financial statements, re-appointment of a director, and a Re. 0.50 per share dividend. Approval for related party transactions was also secured.
The passing of financial statements and dividend declaration are routine positive events. The re-appointment of directors and approval of related party transactions are standard corporate governance actions. The impact is considered medium as it reflects continued operational and governance stability.
All resolutions, including the adoption of financial statements, director re-appointments, dividend declaration, and related party transactions, were passed with the requisite majority, indicating shareholder approval and confidence.
QMS Medical Allied Services Limited held its 9th Annual General Meeting (AGM) on Wednesday, September 30, 2026. The meeting, which commenced at 02:30 P.M. (IST) and concluded at 02:51 P.M. (IST), was conducted through Video Conferencing.
During the AGM, shareholders approved six resolutions with the requisite majority. These included the adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026. Shareholders also re-appointed Mr. Mahesh Pahalraj Makhija as a Director and approved the regularization of Mr. Pranav Manhar Badheka as an Independent Director.
A final dividend of Re. 0.50 (5%) per equity share for the financial year ended March 31, 2026, was also declared and approved. Additionally, approval was granted for material related party transactions with the subsidiary, Saarathi Healthcare Private Limited.
The voting results, combining remote e-voting and e-voting conducted at the AGM, were consolidated and submitted along with the Scrutinizer’s Report as per SEBI regulations. The results of the remote e-voting are expected to be announced on or before October 05, 2026, and will be available on the company's website and the stock exchange.
What to do with a filing like this
QMS Medical Allied Services Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by QMS Medical Allied Services Limited. Read the original for the full detail.